In vitro efects of bufotenine against RNA and DNA viruses


Butantan affiliation
Publication type
Article
Language
English
Access rights
Restricted access
Appears in Collections:
Metrics
Abstract
Bufotenine, an alkaloid that can be found in plant extracts and skin secretions of amphibians, is reported to have potential antiviral activity. The present study evaluated the antiviral activity of bufotenine against different genetic lineages of rabies virus (RABV, a single-stranded, negative-sense RNA virus), canine coronavirus (CCoV, a positive-sense RNA virus) and two double-stranded DNA viruses (two strains of herpes simplex virus type 1/HSV-1 [KOS and the acyclovir-resistant HSV-1 strain 29R] and canine adenovirus 2, CAV-2). The maximal non-toxic bufotenine concentrations in Vero and BHK-21 cells were determined by MTT assays. The antiviral activity of bufotenine against each virus was assessed by examination of reductions in infectious virus titres and plaque assays. All experiments were performed with and without bufotenine, and the results were compared. Bufotenine demonstrated significant RABV inhibitory activity. No antiviral action was observed against CCoV, CAV-2 or HSV-1. These findings indicate that the antiviral activity of bufotenine is somewhat linked to the particular infectious dose used and the genetic lineage of the virus, although the mechanisms of its effects remain undetermined.
Reference
Barboza CM, Pimenta DC, Barros HVD, Silva ACR, Garcia JG, Zamudio RM, et al. In vitro efects of bufotenine against RNA and DNA viruses. Braz. J. Microbiol.. 2021 Sept;in press. doi:10.1007/s42770-021-00612-1.
Link to cite this reference
https://repositorio.butantan.gov.br/handle/butantan/3956
Issue Date
2021


Files in This Item:

Existing users please Login
10.1007s42770-021-00612-1.pdf
Description:
Size: 831.69 kB
Format: Adobe PDF
Embargoed until January 1, 2999    Request a copy
Show full item record

The access to the publications deposited in this repository respects the licenses from journals and publishers.